Akums Drugs and Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
AKUMS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Akums Drugs and Pharmaceuticals has informed the stock exchanges that its trading window will be closed for all designated persons (including their immediate relatives) starting October 1, 2025. The window will remain shut until 48 hours after the company declares its unaudited financial results for the quarter and half year ending September 30, 2025. This is a routine compliance measure under SEBI's Insider Trading Regulations, 2015. The exact date of the board meeting to approve these Q2/H1 results has not yet been announced and will be communicated later.
No direct impact on regular retail shareholders — this restriction applies only to company insiders and their relatives. However, the upcoming Q2 and H1 FY26 results declaration is worth watching as it may influence the stock price.